Her case reflects a pattern seen in many filings and in this case, tragically, it was fatal." As part of the multidistrict litigation, Motley Rice is also representing Todd Engel, a 62-year-old man from Maryland who sued Novo Nordisk in April 2025, alleging he became legally blind after taking Ozempic
This unique dual action sets tirzepatide apart from older medications by targeting two crucial pathwaysultimately leading to reduced appetite, prolonged satiety, improved insulin sensitivity, and increased calorie burning
Ozempic no est aprobado por la FDA para la prdida de peso o el manejo crnico del peso, remarcan
Proc Natl Acad Sci USA 105, 50345039 (2008)
En cuanto a la cobertura, seala que "para diabetes suele haber algn nivel de cobertura, pero para obesidad es una lucha constante, porque muchas obras sociales y prepagas todava no la reconocen como una enfermedad"
& Frhlich, D